Insider Trading History of Metzger Michael A

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Metzger Michael A since 2018. This trader's CIK number is 1507220. At the time of last reporting, Metzger Michael A was the Chief Executive Officer of Syndax Pharmaceuticals Inc. (stock ticker symbol SNDX). Also see all insider trading activities at Syndax Pharmaceuticals Inc.

Note that in the past Metzger Michael A also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Syndax Pharmaceuticals Inc (SNDX) by Metzger Michael A

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 SNDX 0 $0 28,636 $393,531 13,888 $99,992
2023 SNDX 0 $0 5,959 $164,694 5,959 $38,018
2022 SNDX 0 $0 62,942 $1,394,308 62,942 $440,360
2021 SNDX 0 $0 320,000 $6,217,040 320,000 $2,291,860
2020 SNDX 0 $0 115,000 $2,375,920 115,000 $828,000

Yearly summary of insider trading at Cti Biopharma Corp (CTIC) by Metzger Michael A

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 CTIC 0 $0 203,121 $1,204,035 183,000 $161,222
2018 CTIC 0 $0 0 $0 20,121 $0


Insider trading activities at 2 companies by Metzger Michael A:

1. Syndax Pharmaceuticals Inc (SNDX)

2. Cti Biopharma Corp (CTIC)

Table 1. Insider trading of Syndax Pharmaceuticals Inc (SNDX) by Metzger Michael A

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-07-16 SNDX Sale 7,534 9.29 69,953
2025-03-14 SNDX Option Ex 6,074 7.20 43,732
2025-03-04 SNDX Option Ex 7,814 7.20 56,260
2025-03-04 SNDX Sale 7,814 15.04 117,561
2025-02-10 SNDX Sale 13,288 15.50 206,017
2023-02-06 SNDX Sale 5,959 27.64 164,694
2023-02-06 SNDX Option Ex 5,959 6.38 38,018
2022-10-06 SNDX Sale 16,231 25.29 410,514
2022-10-06 SNDX Option Ex 16,231 8.77 142,345
2022-07-25 SNDX Option Ex 31,602 6.38 201,620
2022-07-25 SNDX Sale 31,602 21.05 665,380
2022-07-06 SNDX Option Ex 15,009 6.38 95,757
2022-07-07 SNDX Option Ex 100 6.38 638
2022-07-06 SNDX Sale 15,009 21.07 316,314
2022-07-07 SNDX Sale 100 21.00 2,100
2021-12-16 SNDX Option Ex 22,715 6.38 144,921
2021-12-17 SNDX Option Ex 1,676 6.38 10,692
2021-12-16 SNDX Sale 22,715 19.08 433,402
2021-12-17 SNDX Sale 1,676 19.02 31,877
2021-12-20 SNDX Option Ex 61,000 7.58 462,075
2021-12-20 SNDX Sale 61,000 20.29 1,237,568
2021-12-13 SNDX Option Ex 36,609 6.79 248,575
2021-12-13 SNDX Sale 36,609 19.05 697,511
2021-10-26 SNDX Sale 16,296 19.20 312,818
2021-10-25 SNDX Sale 44,704 19.13 855,321
2021-10-26 SNDX Option Ex 16,296 7.20 117,331
2021-10-25 SNDX Option Ex 44,704 7.20 321,868
2021-09-27 SNDX Option Ex 24,437 7.20 175,946
2021-09-27 SNDX Sale 24,437 19.51 476,839
2021-09-22 SNDX Sale 300 19.02 5,706
2021-09-21 SNDX Sale 4,808 19.16 92,106
2021-09-22 SNDX Option Ex 300 7.20 2,160
2021-09-20 SNDX Sale 31,455 19.23 605,036
2021-09-21 SNDX Option Ex 4,808 7.20 34,617
2021-09-20 SNDX Option Ex 31,455 7.20 226,476
2021-09-13 SNDX Option Ex 16,651 7.20 119,887
2021-09-14 SNDX Option Ex 44,349 7.20 319,312
2021-09-13 SNDX Sale 16,651 19.02 316,635
2021-09-14 SNDX Sale 44,349 19.15 849,416
2021-02-01 SNDX Sale 15,000 20.19 302,805
2021-02-01 SNDX Option Ex 15,000 7.20 108,000
2020-12-01 SNDX Option Ex 15,000 7.20 108,000
2020-12-01 SNDX Sale 15,000 22.97 344,520
2020-11-04 SNDX Option Ex 100,000 7.20 720,000
2020-11-04 SNDX Sale 100,000 20.31 2,031,400

Table 2. Insider trading of Cti Biopharma Corp (CTIC) by Metzger Michael A

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-11-08 CTIC Option Ex 91,500 .92 84,271
2022-11-08 CTIC Sale 91,500 5.63 514,779
2022-07-07 CTIC Sale 20,121 6.53 131,289
2022-07-05 CTIC Sale 91,500 6.10 557,967
2022-07-05 CTIC Option Ex 91,500 .84 76,951
2018-01-20 CTIC Option Ex 20,121 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Metzger Michael A (Chief Executive Officer of Syndax Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.